Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease

Gastroenterology

Volumn 128, Issue 7, 2005, Pages 2020-2028

  Targan, Stephan R ^a   Landers, Carol J ^a   Yang, Huiying ^a   Lodes, Michael J ^a,b   Cong, Yingzi ^a,c   Papadakis, Konstantinos A ^a   Vasiliauskas, Eric ^a   Elson, Charles O ^a,c   Hershberg, Robert M ^a,d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CombiMatrix Corporation ^*  (United States)

^c University of Alabama at Birmingham   (United States)

^d Dendreon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CBIR1 ANTIBODY; CELL NUCLEUS ANTIGEN; FLAGELLIN; FUNGUS ANTIBODY; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN C; PROTEIN ANTIBODY; PROTEIN CBIR1; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS; UNITED STATES;

EID: 20444441016     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.03.046     Document Type: Article

References (35)

1. W. Strober, I.J. Fuss, R.S. Blumberg The immunology of mucosal models of inflammation Annu Rev Immunol 20 2002 495 549
2. R.S. Blumberg, L.J. Saubermann, W. Strober Animal models of mucosal inflammation and their relation to human inflammatory bowel disease Curr Opin Immunol 11 1999 648 656
3. H. De Winter, H. Cheroutre, M. Kronenberg Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model Am J Physiol 276 1999 G1317 G1321
4. Y. Cong, S.L. Brandwein, R.P. McCabe, A. Lazenby, E.H. Birkenmeier, J.P. Sundberg, C.O. Elson CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice increased T helper cell type 1 response and ability to transfer disease J Exp Med 187 1998 855 864
5. Y. Cong, C.T. Weaver, A. Lazenby, C.O. Elson Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12 J Immunol 165 2000 2173 2182
6. Y. Cong, C.T. Weaver, A. Lazenby, C.O. Elson Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora J Immunol 169 2002 6112 6119
7. S.L. Brandwein, R.P. McCabe, Y. Cong, K.B. Waites, B.U. Ridwan, P.A. Dean, T. Ohkusa, E.H. Birkenmeier, J.P. Sundberg, C.O. Elson Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora J Immunol 159 1997 44 52
8. S.C. Kim, S. Tonkonogy, C. Albright, R.B. Sartor Regional and host specificity of colitis in mice monoassociated with different non-pathogenic bacteria Gastroenterology 124 2003 A-485
9. G.R. D'Haens, K. Geboes, M. Peeters, F. Baert, F. Penninckx, P. Rutgeerts Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 1998 262 267
10. P. Rutgeerts, K. Goboes, M. Peeters, M. Hiele, F. Penninckx, R. Aerts, R. Kerremans, G. Vantrappen Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum Lancet 338 1991 771 774
11. C. Prantera, A. Kohn, R. Mangiarotti, A. Andreoli, C. Luzi Antimycobacterial therapy in Crohn's disease results of a controlled, double-blind trial with a multiple antibiotic regimen Am J Gastroenterol 89 1994 513 518
12. C. Prantera, F. Zannoni, M.L. Scribano, E. Berto, A. Andreoli, A. Kohn, C. Luzi An antibiotic regimen for the treatment of active Crohn's disease a randomized, controlled clinical trial of metronidazole plus ciprofloxacin Am J Gastroenterol 91 1996 328 332
13. C. Prantera, A. Kohn, F. Zannoni, N. Spimpolo, M. Bonfa Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn's disease results of an open study J Clin Gastroenterol 19 1994 79 80
14. P. Rutgeerts, M. Hiele, K. Geboes, M. Peeters, F. Penninckx, R. Aerts, R. Kerremans Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection Gastroenterology 108 1995 1617 1621
15. M. Guslandi, G. Mezzi, M. Sorghi, P.A. Testoni Saccharomyces boulardii in maintenance treatment of Crohn's disease Dig Dis Sci 45 2000 1462 1464
16. R. Duchmann, E. May, M. Heike, P. Knolle, M. Neurath, K.H. Meyer zum Buschenfelde T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans Gut 44 1999 812 818
17. C.J. Landers, O. Cohavy, R. Misra, H. Yang, Y.C. Lin, J. Braun, S.R. Targan Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens Gastroenterology 123 2002 689 699
18. E.A. Vasiliauskas, S.E. Plevy, C.J. Landers, S.W. Binder, D.M. Ferguson, H. Yang, J.I. Rotter, A. Vidrich, S.R. Targan Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup Gastroenterology 110 1996 1810 1819
19. E.A. Vasiliauskas, L.Y. Kam, L.C. Karp, J. Gaiennie, H. Yang, S.R. Targan Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics Gut 47 2000 487 496
20. W.S. Mow, E.A. Vasiliauskas, Y.C. Lin, P.R. Fleshner, K.A. Papadakis, K.D. Taylor, C.J. Landers, M.T. Abreu-Martin, J.I. Rotter, H. Yang, S.R. Targan Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease Gastroenterology 126 2004 414 424
21. M.J. Lodes, Y. Cong, C.O. Elson, R. Mohamath, C.J. Landers, S.R. Targan, M. Fort, R.M. Hershberg Bacterial flagellin is a dominant antigen in Crohn disease J Clin Invest 113 2004 1296 1306
22. N. Esters, S. Vermeire, S. Joossens, M. Noman, E. Louis, J. Belaiche, M. De Vos, A. Van Gossum, P. Pescatore, R. Fiasse, P. Pelckmans, H. Reynaert, D. Poulain, X. Bossuyt, P. Rutgeerts Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease Am J Gastroenterol 97 2002 1458 1462
23. M. Peeters, S. Joossens, S. Vermeire, R. Vlietinck, X. Bossuyt, P. Rutgeerts Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease Am J Gastroenterol 96 2001 730 734
24. I.D.R. Arnott, C.J. Landers, E.J. Nimmo, H.E. Drummond, S.R. Targan, J. Satsangi Reactivity to microbial components in Crohn's disease is associated with severity and progression Am J Gastroenterol 99 2004 2376 2384
25. J. Main, H. McKenzie, G.R. Yeaman, M.A. Kerr, D. Robson, C.R. Pennington, D. Parratt Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease BMJ 297 1988 1105 1106
26. M. Eggena, O. Cohavy, M.H. Parseghian, B.A. Hamkalo, D. Clemens, S.R. Targan, L.K. Gordon, J. Braun Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA J Autoimmun 14 2000 83 97
27. M. Eggena, S.R. Targan, L. Iwanczyk, A. Vidrich, L.K. Gordon, J. Braun Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis J Immunol 156 1996 4005 4011
28. L.K. Gordon, M. Eggena, S.R. Targan, J. Braun Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA Invest Ophthalmol Vis Sci 40 1999 1250 1255
29. L.K. Gordon, M. Eggena, S.R. Targan, J. Braun Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies Clin Immunol 94 2000 42 50
30. O. Cohavy, D. Bruckner, L.K. Gordon, R. Misra, B. Wei, M.E. Eggena, S.R. Targan, J. Braun Colonic bacteria express an ulcerative colitis pANCA-related protein epitope Infect Immun 68 2000 1542 1548
31. H. Dalwadi, B. Wei, M. Kronenberg, C.L. Sutton, J. Braun The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen Immunity 15 2001 149 158
32. F. Seibold, S. Brandwein, S. Simpson, C. Terhorst, C.O. Elson pANCA represents a cross-reactivity to enteric bacterial antigens J Clin Immunol 18 1998 153 160
33. L. Liaudet, A. Deb, P. Pacher, J.G. Mabley, K.G. Murthy, A.L. Salzman, C. Szabo The flagellin-TLR5 axis therapeutic opportunities Drug News Perspect 15 2002 397 409
34. F. Hayashi, K.D. Smith, A. Ozinsky, T.R. Hawn, E.C. Yi, D.R. Goodlett, J.K. Eng, S. Akira, D.M. Underhill, A. Aderem The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 410 2001 1099 1103
35. T.K. Means, F. Hayashi, K.D. Smith, A. Aderem, A.D. Luster The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells J Immunol 170 2003 5165 5175